Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
01/21/20209:00AMPR Newswire (Canada)US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory...NYSE:GSKGSK plc
01/02/20204:26PMDow Jones NewsDrug Prices Climb by 5.8% on Average, Less Than Last YearNYSE:GSKGSK plc
12/16/20196:59PMDow Jones NewsGlaxoSmithKline: Study Shows Blood Cancer Drug Works in Heavily Treated PatientsNYSE:GSKGSK plc
12/16/20196:40PMPR Newswire (US)Pivotal DREAMM-2 study demonstrated a clinically meaningful overall response rate with belantamab mafodotin (GSK2857916) for ...NYSE:GSKGSK plc
12/16/20196:36PMPR Newswire (Canada)Pivotal DREAMM-2 study demonstrated a clinically meaningful overall response rate with belantamab mafodotin (GSK2857916) for ...NYSE:GSKGSK plc
12/16/20196:36PMPR Newswire (US)Pivotal DREAMM-2 study demonstrated a clinically meaningful overall response rate with belantamab mafodotin (GSK2857916) for ...NYSE:GSKGSK plc
12/03/20199:09PMDow Jones NewsCorporate Tax Chiefs Voice Concerns About Global Minimum Tax ProposalNYSE:GSKGSK plc
11/12/201911:36AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
11/08/20191:38PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
11/06/201912:00PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
11/05/20198:45AMInvestorWireNew Hope in the Battle Against Ovarian CancerNYSE:GSKGSK plc
11/04/20191:19PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
11/01/20192:22PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
11/01/201912:28PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/31/201911:27AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/30/20192:21PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/30/20191:55PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/30/20199:56AMDow Jones NewsGlaxoSmithKline Raises Guidance After 3Q Profit Rise -- UpdateNYSE:GSKGSK plc
10/30/20198:52AMDow Jones NewsGlaxoSmithKline Raises Outlook as 3Q Revenue, Profit GrowNYSE:GSKGSK plc
10/29/20198:45AMInvestorWireDelivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer TherapeuticsNYSE:GSKGSK plc
10/23/20195:36PMBusiness WireGSK Announces U.S. Food & Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatmen...NYSE:GSKGSK plc
10/21/20196:35AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/21/20194:12AMDow Jones NewsGlaxoSmithKline to Sell Two Former Novartis Vaccines for up to EUR955 MillionNYSE:GSKGSK plc
10/15/20191:07PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/15/20191:01PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/15/201912:54PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/15/201912:50PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/15/201912:25PMDow Jones NewsEUROPE MARKETS: European Stocks Surge To Best Level In 16 Months On Brexit Optimism, U.S. EarningsNYSE:GSKGSK plc
10/15/201912:23PMDow Jones NewsEUROPE MARKETS: European Stocks Surge To Best Level In 16 Months On Brexit Optimism, U.S. EarningsNYSE:GSKGSK plc
10/15/201911:58AMDow Jones NewsLONDON MARKETS: Pound Surges On Report Of Possible Draft Brexit DealNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK